These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 41558)

  • 1. The spectrofluorimetric estimation and buccal absorption of SL 75212, a novel beta-adrenoceptor antagonist [proceedings].
    Davis BJ; Turner P
    Br J Clin Pharmacol; 1979 Oct; 8(4):405P. PubMed ID: 41558
    [No Abstract]   [Full Text] [Related]  

  • 2. Buccal absorption characteristics of some selective and non-selective beta-adrenoceptor agonists and antagonists [proceedings].
    Ohashi K; Turner P
    Br J Clin Pharmacol; 1980 Jan; 9(1):120P. PubMed ID: 6101954
    [No Abstract]   [Full Text] [Related]  

  • 3. The buccal absorption of some -adrenoceptor blocking drugs.
    Hicks DC
    Br J Pharmacol; 1973 Mar; 47(3):680P-681P. PubMed ID: 4147199
    [No Abstract]   [Full Text] [Related]  

  • 4. The buccal absorption of atenolol and propranolol, and their physicochemical characteristics [proceedings].
    Schürmann W; Turner P
    Br J Clin Pharmacol; 1977 Oct; 4(5):655P-656P. PubMed ID: 911642
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics of the new beta-adrenoceptor blocker SL 75212 in man after repeated oral administration [proceedings].
    Bianchetti G; Blatrix C; Gomeni R; Kilborn JR; Larribaud J; Lücker PW; Morselli PL; Thébault JJ; Trocherie S
    Br J Clin Pharmacol; 1979 Oct; 8(4):408P. PubMed ID: 41560
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the beta-adrenoceptor blocking properties and pharmacokinetics of SL 75212 and propranolol in man [proceedings].
    Bianchetti G; Chauvin M; Giudicelli JF; Gomeni R; Kilborn JR; Morselli PL; Richer C; Thuillez C
    Br J Clin Pharmacol; 1979 Oct; 8(4):407P-708P. PubMed ID: 41559
    [No Abstract]   [Full Text] [Related]  

  • 7. A membrane model of the human oral mucosa as derived from buccal absorption performance and physicochemical properties of the beta-blocking drugs atenolol and propranolol.
    Schürmann W; Turner P
    J Pharm Pharmacol; 1978 Mar; 30(3):137-47. PubMed ID: 24685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of SL 75212 and propranolol in old age, uraemia and in healthy young adults [proceedings].
    Bianchetti G; Brancaccio D; Forette F; Henry JF; Hervy MP; Ganansia J; Gomeni R; Kilborn JR; Morselli PL
    Br J Clin Pharmacol; 1980 Mar; 9(3):299P. PubMed ID: 6102472
    [No Abstract]   [Full Text] [Related]  

  • 9. Spectrofluorometric assay and buccal absorption of LM 5008, a new potential antidepressive drug [proceedings].
    Kaspi T; Blackett A; Turner P
    Br J Clin Pharmacol; 1979 Oct; 8(4):412P. PubMed ID: 508545
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetics of single and multiple doses of flusoxolol (Ro 31-1411) in healthy subjects.
    Gillies HC; Rogers HJ; Francis RJ; Galloway DB; Humphreys JE
    Eur J Clin Pharmacol; 1986; 31(1):113-5. PubMed ID: 2877883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of the new beta-adrenoceptor blocking agent betaxolol (SL 75212) in man after repeated oral administration.
    Bianchetti G; Blatrix C; Gomeni R; Kilborn JR; Larribaud J; Lücker PW; Thebault JJ; Trocherie S; Morselli PL
    Arzneimittelforschung; 1980; 30(11):1912-6. PubMed ID: 6109538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the metabolism of the beta-adrenoceptor antagonists alprenolol, metoprolol and pamatolol.
    Hoffmann K
    Acta Pharm Suec; 1979; 16(2):160. PubMed ID: 38629
    [No Abstract]   [Full Text] [Related]  

  • 13. Dose dependent disposition of [14C]-ICI 89,406 in the male rat: is this due to a capacity limited excretory pathway for the drug into bile? [proceedings].
    Barnfield DJ; Bourne GR; Lowery C; Moss SR
    Br J Pharmacol; 1979 Jul; 66(3):492P. PubMed ID: 43182
    [No Abstract]   [Full Text] [Related]  

  • 14. Recovery of propranolol after buccal absorption [proceedings].
    Henry JA; Ohashi K
    Br J Clin Pharmacol; 1979 Oct; 8(4):406P. PubMed ID: 508541
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetic studies on the selective beta1-receptor antagonist metoprolol in man.
    Regårdh CG; Borg KO; Johansson R; Johnsson G; Palmer L
    J Pharmacokinet Biopharm; 1974 Aug; 2(4):347-64. PubMed ID: 4155762
    [No Abstract]   [Full Text] [Related]  

  • 16. The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
    Baker JG
    Br J Pharmacol; 2005 Feb; 144(3):317-22. PubMed ID: 15655528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buccal absorption of verapamil-evidence for membrane storage [proceedings].
    Davis BJ; Johnston A
    Br J Clin Pharmacol; 1979 Apr; 7(4):434P. PubMed ID: 444383
    [No Abstract]   [Full Text] [Related]  

  • 18. Proceedings: Relationship between the pharmacokinetic and pharmacodynamic properties of the beta-receptor antagonists alprenolol and metoprolol.
    Regardh CG; Ablad B; Borg KO; Johnsson G; Solvell L
    Acta Pharm Suec; 1974 Dec; 11(6):660. PubMed ID: 237405
    [No Abstract]   [Full Text] [Related]  

  • 19. Species differences in the metabolism of pamatolol, a cardioselective beta--adrenoceptor antagonist.
    Hoffmann KJ; Skånberg I; Borg KO
    Eur J Drug Metab Pharmacokinet; 1979; 4(3):163-73. PubMed ID: 43252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proceedings: The influence of nitrogen, chain and ring substitution on some physico-organic properties and on buccal absorption of amphetamines.
    Beckett AH; Grech O; Mihailova D
    J Pharm Pharmacol; 1975 Dec; 27 Suppl?-2():67P. PubMed ID: 2743
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.